(Q44405624)

2 December 2017

Age-dependent biphasic changes in ischemic sensitivity in the striatum of Huntington's disease R6/2 transgenic mice (English)

1 reference

2 December 2017

0 references

1 reference

Gloria J Klapstein

1

1 reference

PubMed ID

15371492

2 December 2017

Michael S Levine

series ordinal

2

1 reference

PubMed ID

15371492

2 December 2017

language of work or name

English

0 references

publication date

15 September 2004

1 reference

Journal of Neurophysiology

2 December 2017

1 reference

2 December 2017

93

1 reference

2 December 2017

2

1 reference

2 December 2017

758-765

1 reference

Replicating Huntington's disease phenotype in experimental animals

2 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

NMDA receptor function in mouse models of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Biphasic developmental changes in Ca2+/calmodulin-dependent proteins in R6/2 Huntington's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Coupling of cellular energy state and ion homeostasis during recovery following brain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Involvement of superoxide in excitotoxicity and DNA fragmentation in striatal vulnerability in mice after treatment with the mitochondrial toxin, 3-nitropropionic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Calbindin-D28k fails to protect hippocampal neurons against ischemia in spite of its cytoplasmic calcium buffering properties: evidence from calbindin-D28k knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Energy metabolism defects in Huntington's disease and effects of coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Maturation of vulnerability to excitotoxicity: intracellular mechanisms in cultured postnatal hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Huntington's disease transgenic mice are resistant to global cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Adaptation of adult brain tissue to anoxia and hypoxia in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

The mechanism of neuronal resistance and adaptation to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Secondary abnormalities of mitochondrial DNA associated with neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Transient neuronal depolarization induces tolerance to subsequent forebrain ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Mechanisms underlying the rapid depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Hypoxia-ischemia induces a rapid elevation of ubiquitin conjugate levels and ubiquitin immunoreactivity in the immature rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Induction of ischemic tolerance in rat cortical neurons by 3-nitropropionic acid: chemical preconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

The effect of age on susceptibility to brain damage in a model of global hemispheric hypoxia-ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Hyperglycemia and the rate of lactic acid accumulation during cerebral ischemia in developing animals: in vivo proton MRS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00483.2004

21 January 2018

Identifiers

DOI

10.1152/JN.00483.2004

1 reference

2 December 2017

1 reference

PubMed ID

15371492